{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"66.74","upperLimit":"90.85","value":"80.85"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"47"}],"units":"Participants"}],"dispersionType":"95% Confidence Interval","groups":[{"description":"All regimens were analyzed together.","id":"OG000","title":"All Participants"}],"paramType":"NUMBER","populationDescription":"All participants","reportingStatus":"POSTED","timeFrame":"Within 6 months after PBSCT","title":"Incidence of Infections, Including Bacterial, Fungal, and Viral Infections (i.e., CMV and EBV Reactivation, Including Post-transplant Lymphoproliferative Disorders)","type":"SECONDARY","unitOfMeasure":"percentage of participants"}